Literature DB >> 11000248

Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.

S K Ghosh1, P Roy-Burman, D V Faller.   

Abstract

We have previously reported that the long terminal repeat (LTR) region of feline leukemia viruses (FeLVs) can enhance expression of certain cellular genes such as the collagenase IV gene and MCP-1 in trans (S. K. Ghosh and D. V. Faller, J. Virol. 73:4931-4940, 1999). Genomic DNA of all healthy feline species also contains LTR-like sequences that are related to exogenous FeLV LTRs. In this study, we evaluated the cellular gene transactivational potential of these endogenous FeLV LTR sequences. Unlike their exogenous FeLV counterparts, neither nearly full-length endogenous FeLV molecular clones (CFE-6 and CFE-16) nor their isolated LTRs were able to activate collagenase IV gene or MCP-1 expression in transient transfection assays. We had also demonstrated previously that production of an RNA transcript from exogenous FeLV LTRs correlates with their transactivational activity. In the present study, we demonstrate that the endogenous FeLV LTRs do not generate LTR-specific RNA transcripts in the feline embryo fibroblast cell line AH927. Furthermore, infection of AH927 cells by an exogenous FeLV subgroup A virus did not induce production of such LTR-specific transcripts from the endogenous proviral genomes, although the LTR-specific transcripts from the exogenous virus were readily detected. Finally, LTR-specific transcripts were not generated in BALB/3T3 cells transiently transfected with isolated CFE-6 LTR, in contrast to transfections with LTRs from exogenous viruses. Our data thus suggest that the inability of endogenous FeLV LTRs in gene transactivation is not due to cell line specificity or presence of any upstream inhibitory cis-acting element. Endogenous, nonleukemogenic FeLV LTRs, therefore, do not transactivate cellular gene expression, and this property appears to be specific to exogenous, leukemogenic FeLVs.

Entities:  

Mesh:

Year:  2000        PMID: 11000248      PMCID: PMC112408          DOI: 10.1128/jvi.74.20.9742-9748.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  RD-114 and feline leukaemia virus genome expression in natural lymphomas of domestic cats.

Authors:  H L Niman; J R Stephenson; M B Gardner; P Roy-Burman
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

3.  CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.

Authors:  A L Zaiman; A Nieves; J Lenz
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes.

Authors:  S Y Choi; D V Faller
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

5.  Differential expression of two distinct endogenous retrovisus genomes in developing tissues of the domestic cat.

Authors:  H L Niman; M Akhavi; M B Gardner; J R Stephenson; P Roy-Burman
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

6.  Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

Authors:  S K Ghosh; D V Faller
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Evolution of type C viral genes: origin of feline leukemia virus.

Authors:  R E Benveniste; C J Sherr; G J Todaro
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

8.  Cloning of endogenous murine leukemia virus-related sequences from chromosomal DNA of BALB/c and AKR/J mice: identification of an env progenitor of AKR-247 mink cell focus-forming proviral DNA.

Authors:  A S Khan; W P Rowe; M A Martin
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Human-specific integrations of the HERV-K endogenous retrovirus family.

Authors:  P Medstrand; D L Mager
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library.

Authors:  L H Soe; B G Devi; J I Mullins; P Roy-Burman
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  3 in total

1.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

2.  Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Authors:  Lora W Forman; Ruma Pal-Ghosh; Remco A Spanjaard; Douglas V Faller; Sajal K Ghosh
Journal:  FEBS Lett       Date:  2009-03-29       Impact factor: 4.124

3.  High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings.

Authors:  M Suntz; K Failing; W Hecht; D Schwartz; M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  2010-03-25       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.